The following fields were updated due to additional information: b.5.Describe event or problem: it was reported that 15 bd safetyglide¿ needles from lot 2025238, 1 needle each from lots 2025237 and 2195356 were blocked during use.There were multiple lot numbers reported to be involved.The information for each lot number is as follows: d.4.Medical device lot #: 2025238 d.4.Medical device expiration date: 31-dec-2026 h.4.Device manufacture date: 25-jan-2022 d.4.Medical device lot #: 2025237 d.4.Medical device expiration date: 31-dec-2026 h.4.Device manufacture date: 25-jan-2022 d.4.Medical device lot #: 2195356 d.4.Medical device expiration date: 30-jun-2027.H.4.Device manufacture date: 14-jul-2022 h6: investigation summary it was reported the needle was occluded.To aid in the investigation, twenty-nine samples were received for evaluation by our quality team.One sample came in a sealed packaging blister with lot 2195356.The remaining twenty-eight samples came with no packaging blisters.A visual inspection was performed and no defects or imperfections were observed.Each sample was then connected to a syringe with saline solution.The sample in the sealed packaging blister expelled the solution with a normal flow.From the additional twenty-eight samples.Twenty-six samples expelled the solution with a normal flow and two did not; these two needles are clogged.A device history record review was completed for provided material number 305916, lot numbers 2025237, 2025238 and 2195356.The review revealed all visual inspections were performed as per requirement with no quality notifications related to the complaint defect.Lots 2025237, 2025238 and 2195356 were inspected and accepted based on meeting our inspection control plan and subsequently approved for shipment.Additional device histories were reviewed for each batch of needles used in the manufacturing of this batch.During the history review, additional lots were identified as having suffered from clogged needles due to silicone.It could be possible some samples are escapes from the incident that occurred during production.Several quality initiatives have been implemented on our manufacturing line to ensure that the needle lubricant application is properly applied during the manufacturing process.Additionally, a monitoring program is also in place to verify the needle lubricant is applied uniformly to the needle.Based on the investigation and with the returned sample analysis the symptom reported by the customer is confirmed.
|